Education
About Us
Working with TipRanks
Follow Us
Britannia Life Sciences Inc (TSE:BLAB)
:BLAB
RESEARCH TOOLSreports
BLAB Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.10
Previous CloseN/A
Volume35.00K
Average Volume (3M)9.08K
Market Cap
C$9.74M
Enterprise ValueC$21.21M
Total Cash (Recent Filing)C$990.37K
Total Debt (Recent Filing)C$7.11M
Price to Earnings (P/E)―
Beta-0.90
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding162,254,330
10 Day Avg. Volume4,100
30 Day Avg. Volume9,076
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)2.19
Price to Sales (P/S)0.00
P/FCF Ratio17.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Britannia Life Sciences Inc News
PremiumCompany Announcements
Britannia Life Sciences Strengthens Financial Position with Strategic Sale
PremiumCompany Announcements
Britannia Life Sciences Sells UK Subsidiary to Boost Financial Position
PremiumCompany Announcements
Britannia Life Sciences Reports Successful Shareholder Meeting
PremiumCompany Announcements
Britannia Life Sciences Launches Strategic Financing DrivePremiumCompany Announcements
Britannia Life Sciences Back on Track with OSC
PremiumCompany Announcements
Britannia Life Sciences Announces Growth and ExpansionPremiumCompany Announcements
Britannia Life Sciences Addresses Cease Trade Concerns
PremiumCompany Announcements
Britannia Life Sciences Inc. Faces Cease Trade Amid Audit DelayOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.23% Public Companies and
Individual Investors
BLAB FAQ
What was Britannia Life Sciences Inc’s price range in the past 12 months?
Britannia Life Sciences Inc lowest stock price was C$0.03 and its highest was C$0.10 in the past 12 months.
What is Britannia Life Sciences Inc’s market cap?
Britannia Life Sciences Inc’s market cap is C$9.74M.
When is Britannia Life Sciences Inc’s upcoming earnings report date?
Britannia Life Sciences Inc’s upcoming earnings report date is Aug 27, 2025 which is in 57 days.
How were Britannia Life Sciences Inc’s earnings last quarter?
Britannia Life Sciences Inc released its earnings results on Mar 03, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Britannia Life Sciences Inc overvalued?
According to Wall Street analysts Britannia Life Sciences Inc’s price is currently Overvalued.
Does Britannia Life Sciences Inc pay dividends?
Britannia Life Sciences Inc does not currently pay dividends.
What is Britannia Life Sciences Inc’s EPS estimate?
Britannia Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Britannia Life Sciences Inc have?
Britannia Life Sciences Inc has 162,254,330 shares outstanding.
What happened to Britannia Life Sciences Inc’s price movement after its last earnings report?
Britannia Life Sciences Inc reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Britannia Life Sciences Inc?
Currently, no hedge funds are holding shares in TSE:BLAB
Company Description
Britannia Life Sciences Inc
Britannia Life Sciences Inc. provides product testing, safety assessment, and compliance services to the cosmetics, nutraceutical, and consumer packaged goods industries in the United Kingdom and internationally. The company is based in Toronto, Canada.
Technical Analysis
Kane Biotech
―
Resverlogix
―
Tetra Bio-Pharma
―
BetterLife Pharma
―
BioVaxys Technology
―